Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Nephrology
Volume 2017 (2017), Article ID 9460671, 7 pages
https://doi.org/10.1155/2017/9460671
Case Report

Nephrologists Hate the Dialysis Catheters: A Systemic Review of Dialysis Catheter Associated Infective Endocarditis

1Department of Nephrology, Maimonides Medical Center, Brooklyn, NY, USA
2Department of Internal Medicine, Maimonides Medical Center, Brooklyn, NY, USA
3Department of Infectious Diseases, Maimonides Medical Center, Brooklyn, NY, USA

Correspondence should be addressed to Ankur Sinha; gro.demsedinomiam@ahnisNA

Received 27 December 2016; Accepted 7 March 2017; Published 20 March 2017

Academic Editor: Władysław Sułowicz

Copyright © 2017 Kalyana C. Janga et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. NIH and U.S. Renal Data System, USRDS 2016 Annual Data Report, 2016.
  2. S. Maraj, L. E. Jacobs, S.-C. Kung et al., “Epidemiology and outcome of infective endocarditis in hemodialysis patients,” The American Journal of the Medical Sciences, vol. 324, no. 5, pp. 254–260, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. K. C. Abbott and L. Y. Agodoa, “Hospitalizations for bacterial endocarditis after initiation of chronic dialysis in the United States,” Nephron, vol. 91, no. 2, pp. 203–209, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. R. M. Klevens, J. R. Edwards, M. L. Andrus et al., “Dialysis surveillance report: National Healthcare Safety Network (NHSN)—data summary for 2006 R,” Seminars in Dialysis, vol. 21, no. 1, pp. 24–28, 2008. View at Google Scholar
  5. B. L. Strom, E. Abrutyn, J. A. Berlin et al., “Risk factors for infective endocarditis: oral hygiene and nondental exposures,” Circulation, vol. 102, no. 23, pp. 2842–2848, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. N. R. Powe, B. Jaar, S. L. Furth, J. Hermann, and W. Briggs, “Septicemia in dialysis patients: incidence, risk factors, and prognosis,” Kidney International, vol. 55, no. 3, pp. 1081–1090, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. R. M. Klevens, J. I. Tokars, and M. Andrus, “Electronic reporting of infections associated with hemodialysis,” Nephrology News & Issues, vol. 19, no. 7, pp. 37–43, 2005. View at Google Scholar · View at Scopus
  8. J. Fernández-Cean, A. Alvarez, S. Burguez, G. Baldovinos, P. Larre-Borges, and M. Cha, “Infective endocarditis in chronic haemodialysis: two treatment strategies,” Nephrology Dialysis Transplantation, vol. 17, no. 12, pp. 2226–2230, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. I. Raad, A.-M. Chaftari, R. Zakhour et al., “Successful salvage of central venous catheters in patients with catheter-related or central line-associated bloodstream infections by using a catheter lock solution consisting of minocycline, EDTA, and 25% ethanol,” Antimicrobial Agents and Chemotherapy, vol. 60, no. 6, pp. 3426–3432, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. R. A. Reitzel, J. Rosenblatt, C. Hirsh-Ginsberg et al., “In vitro assessment of the antimicrobial efficacy of optimized nitroglycerin-citrate-ethanol as a nonantibiotic, antimicrobial catheter lock solution for prevention of central line-associated bloodstream infections,” Antimicrobial Agents and Chemotherapy, vol. 60, no. 9, pp. 5175–5181, 2016. View at Publisher · View at Google Scholar · View at Scopus
  11. Z. Han, S. Y. Liang, and J. Marschall, “Current strategies for the prevention and management of central line-associated bloodstream infections,” Infection and Drug Resistance, vol. 3, pp. 147–163, 2010. View at Publisher · View at Google Scholar
  12. E. Umana, W. Ahmed, and M. A. Alpert, “Valvular and perivalvular abnormalities in end-stage renal disease,” American Journal of the Medical Sciences, vol. 325, no. 4, pp. 237–242, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. E. C. Madu, I. A. D'Cruz, B. Wall, N. Mansour, and S. Shearin, “Transesophageal echocardiographic spectrum of calcific mitral abnormalities in patients with end-stage renal disease,” Echocardiography, vol. 17, no. 1, pp. 29–35, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Kohler, W. Arnold, G. Renschin et al., “Active hepatitis B vaccination of dialysis patients and medical staV,” Kidney International, vol. 25, pp. 124–128, 1984. View at Google Scholar
  15. M. Girndt, U. Sester, M. Sester, H. Kaul, and H. Kohler, “Impaired cellular immune function in patients with end-stage renal failure,” Nephrology Dialysis Transplantation, vol. 14, no. 12, pp. 2807–2810, 1999. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Girndt, H. Kaul, U. Sester et al., “Selective sequestration of cytokine producing mononuclear cells during hemodialysis treat ment,” Journal of the American Society of Nephrology, vol. 8, article 236, 1997. View at Google Scholar
  17. D. L. Robinson, V. G. Fowler, D. J. Sexton, R. G. Corey, and P. J. Conlon, “Bacterial endocarditis in hemodialysis patients,” American Journal of Kidney Diseases, vol. 30, no. 4, pp. 521–524, 1997. View at Publisher · View at Google Scholar
  18. T. L. Smith, M. L. Pearson, K. R. Wilcox et al., “Emergence of vancomycin resistance in Staphylococcus aureus,” The New England Journal of Medicine, vol. 340, no. 7, pp. 493–501, 1999. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Drees and H. Boucher, “New agents for Staphylococcus aureus endocarditis,” Current Opinion in Infectious Diseases, vol. 19, no. 6, pp. 544–550, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. L. C. Pierrotti and L. M. Baddour, “Fungal endocarditis, 1995–2000,” Chest, vol. 122, no. 1, pp. 302–310, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. P. G. Pappas, C. A. Kauffman, D. Andes et al., “Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America,” Clinical Infectious Diseases, vol. 48, no. 5, pp. 503–535, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. C. F. Evans and J. S. Gammie, “Surgical management of mitral valve infective endocarditis,” Seminars in Thoracic and Cardiovascular Surgery, vol. 23, no. 3, pp. 232–240, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Di Salvo, G. Habib, V. Pergola et al., “Echocardiography predicts embolic events in infective endocarditis,” Journal of the American College of Cardiology, vol. 37, no. 4, pp. 1069–1076, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. H. A. Cooper, E. C. Thompson, R. Laureno et al., “Subclinical brain embolization in left-sided infective endocarditis: results from the evaluation by MRI of the brains of patients with left-sided intracardiac solid masses (EMBOLISM) pilot study,” Circulation, vol. 120, no. 7, pp. 585–591, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. P. J. Peters, T. Harrison, and J. L. Lennox, “A dangerous dilemma: management of infectious intracranial aneurysms complicating endocarditis,” Lancet Infectious Diseases, vol. 6, no. 11, pp. 742–748, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. S. L. Robinson, J. M. Saxe, C. E. Lucas et al., “Splenic abscess associated with endocarditis,” Surgery, vol. 112, no. 4, pp. 781–787, 1992. View at Google Scholar · View at Scopus
  27. K. Spiliopoulos, G. Giamouzis, A. Haschemi et al., “Surgical management of infective endocarditis: early and long-term mortality analysis. single- center experience and brief literature review,” Hellenic Journal of Cardiology, vol. 55, no. 6, pp. 462–474, 2014. View at Google Scholar · View at Scopus